Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse

Nature

Volumn 400, Issue 6740, 1999, Pages 173-177

  Schenk, Dale ^a   Barbour, Robin ^a   Dunn, Whitney ^a   Gordon, Grace ^a   Grajeda, Henry ^a   Guldo, Teresa ^a   Hu, Kang ^a   Huang, Jiping ^a   Johnson Wood, Kelly ^a   Khan, Karen ^a   Kholodenko, Dora ^a   Lee, Mike ^a   Liao, Zhenmei ^a   Lieberburg, Ivan ^a   Motter, Ruth ^a   Mutter, Linda ^a   Soriano, Ferdie ^a   Shopp, George ^a   Vasquez, Nicki ^a   Vandevert, Christopher ^a   Walker, Shannan ^a   Wogulis, Mark ^a   Yednock, Ted ^a   Games, Dora ^a   Seubert, Peter ^a   more..

^a ELAN PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; DISEASE COURSE; DYSTROPHY; GENE MUTATION; IMMUNIZATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BRAIN; BUFFERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREUND'S ADJUVANT; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; NEURITES; PEPTIDE FRAGMENTS; POINT MUTATION; SERUM AMYLOID P-COMPONENT; VACCINATION;

ANIMALIA; MUS MUSCULUS;

EID: 0033536163     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/22124     Document Type: Article

References (16)

1. Hyman, B. T. New neuropathological criteria for Alzheimer disease. Arch. Neurol. 55, 1174-1176 (1998).
2. Tanzi, R. E. et al. The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3, 159-168 (1996).
3. Hardy, J. New insights into the genetics of Alzheimer's disease. Ann. Med. 28, 255-258 (1996).
4. Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674 (1992).
5. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
6. Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. Science 264, 1336-1340 (1994).
7. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72 (1997).
8. Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996).
9. Iwatsubo, T. et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53 (1994).
10. Lippa, C. F., Nee, L. E., Mori, H. & St George-Hyslop, P. Aβ-42 deposition precedes other changes in PS-1 Alzheimer's disease, Lancet, 1117-1118 (1998).
11. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527 (1995).
12. Johnson-Wood, K. et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 1550-1555 (1997).
13. Liang, J. S. et al. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci. Lett. 225, 73-76 (1997).
14. McGeer, E. G. & McGeer, P. L. The role of the immune system in neurodegenerative disorders. Mov. Disorders 12, 855-858 (1997).
15. Seubert, P. et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327 (1992).
16. Seubert, P. et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260-263 (1993).